These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1734902)

  • 1. Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months.
    Kremer JM; Phelps CT
    Arthritis Rheum; 1992 Feb; 35(2):138-45. PubMed ID: 1734902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update.
    Weinblatt ME; Weissman BN; Holdsworth DE; Fraser PA; Maier AL; Falchuk KR; Coblyn JS
    Arthritis Rheum; 1992 Feb; 35(2):129-37. PubMed ID: 1734901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis.
    Kremer JM; Lee JK
    Arthritis Rheum; 1986 Jul; 29(7):822-31. PubMed ID: 3741499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A long-term prospective study of the use of methotrexate in rheumatoid arthritis. Update after a mean of fifty-three months.
    Kremer JM; Lee JK
    Arthritis Rheum; 1988 May; 31(5):577-84. PubMed ID: 3288222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abatacept plus methotrexate provides incremental clinical benefits versus methotrexate alone in methotrexate-naive patients with early rheumatoid arthritis who achieve radiographic nonprogression.
    Wells AF; Westhovens R; Reed DM; Fanti L; Becker JC; Covucci A; Keystone EC
    J Rheumatol; 2011 Nov; 38(11):2362-8. PubMed ID: 21885491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Five year clinical evaluation of treatment efficacy with methotrexate in patients with rheumatoid arthritis ].
    Swierkot J; Szechiński J; Wiland P
    Pol Arch Med Wewn; 2000; 103(5-6):267-75. PubMed ID: 11291608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of the long-term efficacy and toxicity of low-dose methotrexate in rheumatoid arthritis.
    Salaffi F; Carotti M; Sartini A; Cervini C
    Clin Exp Rheumatol; 1995; 13(1):23-8. PubMed ID: 7774099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial.
    Bakker MF; Jacobs JW; Welsing PM; Verstappen SM; Tekstra J; Ton E; Geurts MA; van der Werf JH; van Albada-Kuipers GA; Jahangier-de Veen ZN; van der Veen MJ; Verhoef CM; Lafeber FP; Bijlsma JW;
    Ann Intern Med; 2012 Mar; 156(5):329-39. PubMed ID: 22393128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment of destructive rheumatoid arthritis with methotrexate.
    Rau R; Schleusser B; Herborn G; Karger T
    J Rheumatol; 1997 Oct; 24(10):1881-9. PubMed ID: 9330927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, functional, and radiographic benefits of longterm adalimumab plus methotrexate: final 10-year data in longstanding rheumatoid arthritis.
    Keystone EC; van der Heijde D; Kavanaugh A; Kupper H; Liu S; Guérette B; Mozaffarian N
    J Rheumatol; 2013 Sep; 40(9):1487-97. PubMed ID: 23818718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance of Clinical and Radiographic Benefit With Intravenous Golimumab Therapy in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy: Week-112 Efficacy and Safety Results of the Open-Label Long-Term Extension of a Phase III, Double-Blind, Randomized, Placebo-Controlled Trial.
    Bingham CO; Mendelsohn AM; Kim L; Xu Z; Leu J; Han C; Lo KH; Westhovens R; Weinblatt ME;
    Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1627-36. PubMed ID: 25623393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression.
    Atsumi T; Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Yasuda S; Yamanishi Y; Kita Y; Matsubara T; Iwamoto M; Shoji T; Okada T; van der Heijde D; Miyasaka N; Koike T
    Ann Rheum Dis; 2016 Jan; 75(1):75-83. PubMed ID: 26139005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longterm prospective study of methotrexate in rheumatoid arthritis: conclusion after 132 months of therapy.
    Weinblatt ME; Maier AL; Fraser PA; Coblyn JS
    J Rheumatol; 1998 Feb; 25(2):238-42. PubMed ID: 9489813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.
    Smolen JS; Han C; Bala M; Maini RN; Kalden JR; van der Heijde D; Breedveld FC; Furst DE; Lipsky PE;
    Arthritis Rheum; 2005 Apr; 52(4):1020-30. PubMed ID: 15818697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Certolizumab pegol plus methotrexate 5-year results from the rheumatoid arthritis prevention of structural damage (RAPID) 2 randomized controlled trial and long-term extension in rheumatoid arthritis patients.
    Smolen JS; van Vollenhoven R; Kavanaugh A; Strand V; Vencovsky J; Schiff M; Landewé R; Haraoui B; Arendt C; Mountian I; Carter D; van der Heijde D
    Arthritis Res Ther; 2015 Sep; 17(1):245. PubMed ID: 26353833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiographic outcome after three years of patients with early erosive rheumatoid arthritis treated with intramuscular methotrexate or parenteral gold. Extension of a one-year double-blind study in 174 patients.
    Rau R; Herborn G; Menninger H; Sangha O
    Rheumatology (Oxford); 2002 Feb; 41(2):196-204. PubMed ID: 11886970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate dosage reduction in patients with rheumatoid arthritis beginning therapy with infliximab: the Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) trial.
    Fleischmann RM; Cohen SB; Moreland LW; Schiff M; Mease PJ; Smith DB; Keenan G; Kremer JM;
    Curr Med Res Opin; 2005 Aug; 21(8):1181-90. PubMed ID: 16083527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retardation of radiologic progression in rheumatoid arthritis with methotrexate therapy. A controlled study.
    Rau R; Herborn G; Karger T; Werdier D
    Arthritis Rheum; 1991 Oct; 34(10):1236-44. PubMed ID: 1930313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tocilizumab inhibits structural joint damage and improves physical function in patients with rheumatoid arthritis and inadequate responses to methotrexate: LITHE study 2-year results.
    Fleischmann RM; Halland AM; Brzosko M; Burgos-Vargas R; Mela C; Vernon E; Kremer JM
    J Rheumatol; 2013 Feb; 40(2):113-26. PubMed ID: 23322466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.